SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-22-025936
Filing Date
2022-05-12
Accepted
2022-05-12 16:06:19
Documents
88
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0322_immucellcorp.htm   iXBRL 10-Q 973502
2 CERTIFICATION f10q0322ex31_immucellcorp.htm EX-31 9447
3 CERTIFICATION f10q0322ex32_immucellcorp.htm EX-32 4957
  Complete submission text file 0001213900-22-025936.txt   6208999

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE iccc-20220331.xsd EX-101.SCH 74475
5 XBRL CALCULATION FILE iccc-20220331_cal.xml EX-101.CAL 26914
6 XBRL DEFINITION FILE iccc-20220331_def.xml EX-101.DEF 287908
7 XBRL LABEL FILE iccc-20220331_lab.xml EX-101.LAB 569573
8 XBRL PRESENTATION FILE iccc-20220331_pre.xml EX-101.PRE 305016
82 EXTRACTED XBRL INSTANCE DOCUMENT f10q0322_immucellcorp_htm.xml XML 900506
Mailing Address 56 EVERGREEN DRIVE PORTLAND ME 04103
Business Address 56 EVERGREEN DR PORTLAND ME 04103 2078782770
IMMUCELL CORP /DE/ (Filer) CIK: 0000811641 (see all company filings)

IRS No.: 010382980 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-12934 | Film No.: 22917764
SIC: 2835 In Vitro & In Vivo Diagnostic Substances